Luc G. Berthiaume

Person

Edmonton, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Synthetic lethality and the treatment of cancer
- Patent number 12,343,341
- Issue date Jul 1, 2025
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Epigeneiic silencing of NMT2
- Patent number 11,788,145
- Issue date Oct 17, 2023
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Synthetic lethality and the treatment of cancer
- Patent number 11,135,218
- Issue date Oct 5, 2021
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
- Publication number 20250179589
- Publication date Jun 5, 2025
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF N-MYRISTOYL TRANSFERASE (NMT) INHIBITORS IN THE TREATMENT OF...
- Publication number 20240350481
- Publication date Oct 24, 2024
- PACYLEX PHARMACEUTICALS INC.
- Luc G. BERTHIAUME
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
- Publication number 20230374603
- Publication date Nov 23, 2023
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
- Publication number 20220023294
- Publication date Jan 27, 2022
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
- Publication number 20190010555
- Publication date Jan 10, 2019
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
- Publication number 20190000838
- Publication date Jan 3, 2019
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EPIGENETIC SILENCING OF NMT2
- Publication number 20180208990
- Publication date Jul 26, 2018
- PACYLEX PHARMACEUTICALS INC.
- Luc G. BERTHIAUME
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
- Publication number 20150275309
- Publication date Oct 1, 2015
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS IN BREAST CANCER
- Publication number 20150218648
- Publication date Aug 6, 2015
- PACYLEX PHARMACEUTICALS INC.
- Luc Gerard Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
- Publication number 20140227284
- Publication date Aug 14, 2014
- PACYLEX PHARMACEUTICALS INC.
- Luc G. Berthiaume
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Luc G. Berthiaume

Person

Patents Grantslast 30 patents

Synthetic lethality and the treatment of cancer

Epigeneiic silencing of NMT2

Synthetic lethality and the treatment of cancer

Patents Applicationslast 30 patents

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

USE OF N-MYRISTOYL TRANSFERASE (NMT) INHIBITORS IN THE TREATMENT OF...

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

EPIGENETIC SILENCING OF NMT2

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS IN BREAST CANCER

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER